Estimations des analystes de Wall Street pour Ardelyx, Inc. (ARDX): objectif de cours de consensus, recommandations achat/conserver/vente et prévisions de revenus, BPA et EBITDA pour les prochains exercices.
Surprises de Résultats Récentes
| Date | BPA Réel | BPA Estimé | vs Est. |
|---|---|---|---|
| 2026-10-29 | $-0.03 | ||
| 2026-08-06 | $-0.07 | $-0.07 | -7.0% |
| 2026-04-30 | $-0.15 | $-0.13 | -15.4% |
| 2026-02-19 | $0.02 | $0.02 | +0.0% |
| 2025-10-30 | $-0.00 | $-0.06 | +93.3% |
| 2025-08-04 | $-0.08 | $-0.13 | +38.5% |
| 2025-05-01 | $-0.17 | $-0.10 | -70.0% |
| 2025-02-20 | $0.02 | $0.02 | +0.0% |
Ratios de valorisation
| Prix / Valeur comptable | 5.34 |
| EV / EBITDA | -43.87 |
| Rendement du dividende | 0.00% |
Compte de Résultat (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenus | $24.0M | $42.0M | $2.6M | $5.3M | $7.6M | $10.1M | $52.2M | $124.5M | $333.6M | $407.3M |
| Coût des Ventes | $1.3M | $8.4M | $466000 | $600000 | $145000 | $1.0M | $4.1M | $17.8M | $50.6M | $42.6M |
| Marge Brute | $22.7M | $33.6M | $2.1M | $4.7M | $7.4M | $9.1M | $48.0M | $106.7M | $283.1M | $364.7M |
| R&D | $94.2M | $75.5M | $69.4M | $71.7M | $65.1M | $91.1M | $35.2M | $35.5M | $52.3M | $68.5M |
| Frais Généraux | $18.7M | $23.2M | $23.7M | $24.3M | $33.2M | $72.3M | $76.6M | $134.4M | $258.7M | $337.2M |
| Charges Opérationnelles | $112.9M | $98.7M | $93.1M | $95.9M | $98.2M | $163.4M | $111.8M | $169.9M | $311.0M | $405.7M |
| Résultat Opérationnel | -$112.9M | -$65.1M | -$90.9M | -$91.3M | -$90.8M | -$154.3M | -$63.8M | -$63.3M | -$27.9M | -$41.0M |
| EBITDA | -$111.6M | -$60.5M | -$85.1M | -$84.6M | -$85.2M | -$150.9M | -$61.0M | -$55.4M | -$16.7M | -$29.2M |
| Charges d'Intérêt | 0 | 0 | $3.5M | $5.7M | $5.1M | $4.5M | $5.1M | $8.9M | $20.1M | $28.4M |
| Résultat Avant Impôts | -$112.4M | -$63.2M | -$91.3M | -$94.6M | -$94.3M | -$158.2M | -$67.2M | -$65.5M | -$38.9M | -$60.6M |
| Impôts | $29000 | $1.2M | $4000 | $303000 | $2000 | $4000 | $8000 | $547000 | $266000 | $969000 |
| Résultat Net | -$112.4M | -$64.3M | -$91.3M | -$94.9M | -$94.3M | -$158.2M | -$67.2M | -$66.1M | -$39.1M | -$61.6M |
| BPA | $-2.80 | $-1.36 | $-1.62 | $-1.47 | $-1.05 | $-1.52 | $-0.42 | $-0.30 | $-0.17 | $-0.26 |
| BPA Dilué | $-2.80 | $-1.36 | $-1.62 | $-1.47 | $-1.05 | $-1.52 | $-0.42 | $-0.30 | $-0.17 | $-0.26 |
| Actions en Circulation (Diluées) | $40.1M | $47.4M | $56.2M | $64.5M | $89.6M | $104.2M | $158.7M | $219.3M | $235.2M | $241.0M |
Prix
| Prix | $3.39 |
| Capitalisation | $837M |
| Bourse | NASDAQ |
| Pays | US |
Entreprises liées: BCRX · MAZE · NTLA · PHVS · STOK · SYRE · TRVI
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de ARDX: Vue d'ensemble · Financiers · Valorisation · Statistiques · Technique · Actionnariat · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions